Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy

Fabry disease (FD) is a rare X‐linked disorder of lipid metabolism, characterized by the accumulation of globotriaosylceramide (Gb3) due to defective the lysosomal enzyme, α‐galactosidase. Gb3 deposits activate immune‐mediated systemic inflammation, ultimately leading to life‐threatening consequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Li, Wasiak, Sylwia, Tsujikawa, Laura M., Rakai, Brooke D., Stotz, Stephanie C., Wong, Norman C. W., Johansson, Jan O., Sweeney, Michael, Mohan, Connie M., Khan, Aneal, Kulikowski, Ewelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007222/
https://www.ncbi.nlm.nih.gov/pubmed/35417091
http://dx.doi.org/10.1002/prp2.949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007222/
https://www.ncbi.nlm.nih.gov/pubmed/35417091
http://dx.doi.org/10.1002/prp2.949

Ejemplares similares